MHRP Phase 2 Clinical Trial Launches to Evaluate IL-15 Agonist as Therapy to Reduce …,

MHRP last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist, ImmunityBio’s Anktiva® (also called N- …, MHRP last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist, ImmunityBio’s Anktiva® (also called N- …, Read More

Scroll to Top